Evolent Health, Inc. 4
4 · Evolent Health, Inc. · Filed May 12, 2017
Insider Transaction Report
Form 4
McGrane Nicholas
Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2017-05-10$3.84/sh+1,667$6,401→ 132,047 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-05-10−1,667→ 270,460 totalExercise: $3.84Exp: 2024-10-22→ Class A Common Stock (1,667 underlying) - Sale
Class A Common Stock
2017-05-10$24.28/sh−1,667$40,475→ 130,380 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.
- [F2]The shares were sold in multiple transactions at prices ranging from $23.90-$24.65, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The Class A Common Stock exercised vested on November 1, 2015. One fourth of the Class A Common Stock Options granted to the reporting person on October 22, 2014 vested on November 1, 2015; the balance vested or vests at a rate of 6.25% as of the end of each three-month period immediately thereafter during the period beginning on October 23, 2015, the day following the first anniversary of the grant date.